Fiche société
EVD Pharmacy and Medical Company Limited
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| MLC901This is a randomized, controlled, open-label study of MLC901 (NeuroAiD™ II) in patients with mild to moderate ischemic stroke. Eligible participants will be randomized in a 1:1 ratio to receive MLC901 in combination with standard treatment or standard treatment alone for 12 weeks. | Accident vasculaire cérébral, Maladie coronarienne | Phase 4 | À vérifier | Vietnam | À vérifier |
| MLC901This is a randomized, controlled, open-label study of MLC901 (NeuroAiD™ II) in patients with mild to moderate ischemic stroke. Eligible participants will be randomized in a 1:1 ratio to receive MLC901 in combination with standard treatment or standard treatment alone for 12 weeks. | Accident vasculaire cérébral | Phase 4 | À vérifier | Vietnam | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MLC901 | Accident vasculaire cérébral | Phase 4 | NCT07828210 | NAiD-PRO — NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke | RECRUITING |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| MLC901 | Medical and Non-Surgical Strategies for Mild Traumatic Brain Injury. | Korean journal of neurotrauma | ||
| MLC901 | Review and Meta-Analyses of the Effects of MLC601/MLC901 (NeuroAiD) on Post-Stroke Functional and Motor Recovery. | Neurology international | ||
| MLC901 | Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia. | Cerebrovascular diseases extra |